Key result
Inhalation of 40% N2O in patients with occlusive coronary artery disease decreased arterial pressure and myocardial contractility, and increased LVEDP.
Why the study?
Does inhalation of 40% N2O affect myocardial performance in patients with coronary artery disease?
Does inhalation of 40% N2O affect myocardial performance in patients with coronary artery disease?
Answers are grounded in this paper and cite their sources.
Inhalation of 40% nitrous oxide depresses myocardial contractility and increases left ventricular end-diastolic pressure in patients with severe coronary artery disease, indicating a negative inotropic effect in this population.
Inhalation of 40 per cent N2O by nine patients who had occlusive disease in two or more coronary arteries with elevation of left ventricular end-diastolic pressures (LVEDP) significantly decreased arterial pressure (average 5 per cent) and myocardial contractility as measured by dP/dt/CPIP (average 14 per cent), and increased LVEDP (average 21 per cent). N2O had no significant effect in four patients who had angina without angiographically demonstrable coronary arterial disease. It is concluded that N2O depresses myocardial function in patients who have occlusion of the coronary arteries and impaired left ventricular function.
No takes yet. Share an insight, caveat, or question.
Eisele et al. (1976) studied Coronary-artery disease (n=13). N2O (Nitrous oxide) vs. Patients without angiographically demonstrable coronary arterial disease was evaluated on Arterial pressure, myocardial contractility (dP/dt/CPIP), and LVEDP. Inhalation of 40% N2O in patients with occlusive coronary artery disease decreased arterial pressure and myocardial contractility, and increased LVEDP.
Synapse has enriched 10 related papers. Consider them for comparative context: